Efficacy of Four Topical Products to Improve Skin Longevity
Launched by AMAZENTIS SA · Aug 11, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing how well four different skin care products work to help improve the look and health of facial skin, especially focusing on reducing wrinkles and signs of aging. The study will last for eight weeks, and participants will have their skin evaluated through photos and questionnaires about how they feel their skin looks and ages.
People who might join this study are healthy men and women between 40 and 65 years old who have noticeable but not severe wrinkles on their face. Participants should not have any skin conditions or recent cosmetic treatments on their face and must be willing to avoid using other anti-aging products during the study. They will need to visit the study center several times with a clean, makeup-free face and follow certain rules like avoiding tanning and sun exposure without sunscreen. Men will need to come with a clean-shaven face, though some facial hair like a goatee or mustache is allowed. This study is not yet recruiting, but if you fit these criteria and are interested, it could be a chance to try new skincare products while helping researchers learn more about skin aging.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy female and male volunteers aged 40 to 65 years with no signs of skin disorders.
- • Subject is willing and able to read, understand, and provide written Informed Consent and signed photo release.
- • Subject has a score of 3.0 to 6.0 for clinically graded visible facial wrinkles using the Fitzpatrick Classification of Facial Wrinkling scale at Baseline, to determine eligibility for the creams or serum test articles or 3.0 to 6.0 for clinically graded visible wrinkles in the eye area using a wrinkling scale for the eye cream test article.
- • Subject is willing to refrain from applying/using moisturizer, creams, serums or treatment/anti-aging products to their face during the three days prior to Visit 1 (Baseline). Subject's other regular skin products such as cleanser, sunscreen and cosmetics are acceptable.
- • Subject is willing to come to the test facility with a clean face free of makeup and sunscreen prior to all visits.
- • Subject is a regular sunscreen user (uses at least 2 times a week).
- • Subject is willing to avoid direct sun exposure and/or to apply sunscreen to their face in the event of sun exposure.
- • Subject agrees to remove jewelry and false eye lashes before the visits.
- • Subject agrees not to introduce any new personal care products or cosmetics to the face while participating on the study.
- • Subject is willing to avoid use of tanning beds and any use of sunless tanners on the face throughout the study.
- • Subject is willing to follow study instructions and available to attend all the study visits.
- • Male only: Male subjects are willing to come to all visits with a clean-shaven face. Goatee and/or mustache are acceptable.
- Exclusion Criteria:
- • Female only: Pregnant or lactating or planning a pregnancy during the course of the study. (self-reported).
- • Piercing or tattoos including permanent or semi-permanent make-up on the face which may interfere with study assessments.
- • Any conditions on the face that would interfere with evaluations (i.e. full beard, scars, open cuts, sunburn, severe hyperpigmentation, facial hair/peach fuzz, etc.) or active acne or acne marks.
- • Any skin conditions such as rosacea, eczema, psoriasis, seborrheic dermatitis, vitiligo, etc., or is under the treatment of a doctor for any skin condition on the face.
- • Use of a self-tanner/stain on the face within two weeks of the study start.
- • Allergies or sensitivities to facial moisturizer products, similar materials or their ingredients or cosmetics.
- • Insulin-dependent diabetes.
- • Hematological or immune deficiency disease such as HIV positive, AIDS, Systemic Lupus Erythematosus.
- • Recent use within the last 14 days of a chemical peel or is currently using an in-home or professional chemical peel on their facial skin.
- • Subject has had a cosmetic medical procedure in the test area such as injectable anti-wrinkle products (e.g. Botox), facial cosmetic surgery, etc. in the last year.
- • Current use of OTC (over the counter) pain medication ingested in quantities exceeding label use.
- • Use of topical treatments such as OTC (over-the-counter) acne medication, hydroquinone, or hydrocortisone on the face in the last month.
- • Currently participating in another clinical study or trial involving the face.
- • Subject has been diagnosed with any type of cancer especially skin cancer within the past 12 months or treated for cancer in the last 5 years.
- • Subject has any medical condition which, in the opinion of the Investigator, would compromise the safety of the subject or confound study results.
About Amazentis Sa
Amazentis SA is a biotechnology company focused on advancing health through the development of innovative nutritional and therapeutic solutions. With a strong emphasis on scientific research and clinical validation, Amazentis leverages cutting-edge technologies to explore the potential of bioactive compounds in promoting metabolic health and enhancing overall well-being. The company is dedicated to transforming scientific discoveries into effective products that address pressing health challenges while maintaining a commitment to sustainability and evidence-based practices. Through strategic collaborations and rigorous clinical trials, Amazentis aims to contribute significantly to the fields of nutrition and health optimization.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winnipeg, Manitoba, Canada
Patients applied
Trial Officials
Nalini Kaul, PhD
Principal Investigator
Princeton Consumer Research Corp.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported